2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Melanoma: Is There a Significant Antitumor Activity for Low-dose Ipilimumab + Pembrolizumab Immediately Following Progression on PD-1 Ab?

49 views
August 24, 2020
0 Comments
Login to view comments. Click here to Login